The Flexible and Strategic Therapeutics (FASTx) EZ-BAA program is advancing nucleic-acid based platforms to fight viral infections. Learn more and apply today.APPLY NOW
Join BARDA at the Just Breathe – An ARDS Therapeutics Pitch Event (July 24-28, 2023) to virtually present host-directed therapeutic candidates for participation in a planned BARDA-sponsored phase 2 ARDS platform clinical trial.Learn More
Access recordings of the Summit that brought together diverse stakeholders to explore cutting-edge technologies enabling health assessment and monitoring at home.WATCH NOW
Active programs currently accepting submissions
Making vaccines where they're needed when they're needed.
Advancing technologies that help patients with acute respiratory distress syndrome (ARDS), oxygenate their blood, without further straining ARDS patients' lungs.
Empowering people to respond to infectious disease outbreaks through rapidly deployable digital health tools.
Harness a patient's systemic responses to inform on health threats and clinical impact.
Advancing therapies focused on fortifying and restoring balance to the patient's defense mechanisms.
On-demand, at-home detection of biochemical health markers to enable diagnostics and telemedicine services.
Repurposing drugs for biological threats.
Repurposing and advancing innovations against Rad/Nuc threats.
Active programs, but paused for accepting submissions
Repurposing commonly available drugs to rapidly treat conditions caused by exposure to chemical agents.
Apply the utility of novel health ecosystems, stakeholder collaborations, and real world to data to maximize clinical impact.
A diagnostic test to identify any and every pathogen from a single sample.
Enhance the usability of 3D human tissue models ("tissue chips") as tools for drug development.
Past programs, closed and here for reference
Rapid and widely available access to COVID-19 testing in the home setting.
Interpreting physiological signals for pre- or early symptomatic detection of infection.
Develop alternative delivery methods for vaccines and other therapeutics.
We change how the government approaches big health security challenges and threats.
We tackle health security threats by seeking breakthrough devices and technologies.
We model our work on the best practices of the entrepreneurial world.
We use tools and authorities to support new technologies, streamline contracting processes, and launch a network of accelerators.
The team is comprised of scientists and venture entrepreneurs dedicated to identifying threats to health security.